According to Axios, the U.S. Food and Drug Administration (FDA) is considering a “capability-based approach” similar to physician assessment to evaluate medical devices that employ generative artificial intelligence technology.
2026-08-18
According to Axios, the U.S. Food and Drug Administration (FDA) is considering a “capability-based approach” similar to physician assessment to evaluate medical devices that employ generative artificial intelligence technology.
